Associations of Electrocardiographic Abnormalities in Stable Type 2 Diabetes Subjects: Experience from a Tertiary Health Facility in South Eastern Nigeria

Authors

Abstract

Introduction: Cardiovascular abnormalities are prevalent in the setting of diabetes mellitus, even among stable subjects, necessitating the need for a regular cardiovascular disease screening for this group of patients. Electrocardiogram is a simple and reliable screening test for cardiovascular abnormalities that could be easily accessible even in resource poor and rural settings. This study was carried out to determine the association between cardiovascular risk factors and electrocardiographic abnormalities in stable type 2 diabetes subjects in South Eastern Nigeria.

Materials and Methods: One hundred and thirty-six stable adults with type 2 diabetes mellitus were recruited consecutively from the out-patient diabetes clinic of Nnamdi Azikiwe University Teaching Hospital in South Eastern Nigeria. They were assessed for the risk factors for cardiovascular diseases that included smoking, obesity, dyslipidaemia, poor glycaemic control, hypertension, lack of exercise, presence of chronic kidney disease and metabolic syndrome. They also had a 12 lead electrocardiogram done. Results were analyzed using SPSS version 25. P value of ˂ 0.05 was considered significant.

Result: A total of 128 subjects had complete results and were analyzed. There were 63 males and 65 females with a mean age of 58.43 ± 12.85 years and mean diabetes duration of 9.03 ± 7.36 years. A total of 45.3% of the subjects had electrocardiographic abnormalities. Hypertension was present in 54.9%, dyslipidaemia in 91.4%, central obesity in 74.3%, metabolic syndrome in 76.6% and chronic kidney disease in 57.9% of the subjects. Significant association was found between smoking and occurrence of AV block (p = 0.008), central obesity and QRS axis abnormality (p = 0.002), dyslipidaemia and ST segment abnormality (p = 0.001) and lack of exercise and ST segment abnormality (p = 0.000). No significant association was found between age, sex of the subjects, duration of DM, treatment modality for DM, level of glycaemic control, hypertension, presence of CKD and metabolic syndrome and any of the electrocardiographic abnormalities.

Conclusion: Electrocardiographic abnormalities are common in stable type 2 diabetic subjects. There was significant association between smoking habit, central obesity, dyslipidaemia, lack of exercise and ECG abnormalities that included AV block, QRS axis and ST segment abnormalities.

Keywords:

Electrocardiographic abnormalities, stable type 2 diabetes subjects, cardiovascular disease, Nigeria

DOI

https://doi.org/10.22270/jddt.v13i11.6006

Author Biographies

CM Ezeude, Department of Internal Medicine, Nnamdi Azikiwe University, Awka, Nigeria.

Department of Internal Medicine, Nnamdi Azikiwe University, Awka, Nigeria.

MO Nkpozi, Department of Internal Medicine, Abia State University Teaching Hospital, Aba, Nigeria.

Department of Internal Medicine, Abia State University Teaching Hospital, Aba, Nigeria.

MC Abonyi, Department of Internal Medicine, Enugu State University of Science and Technology, Enugu, Nigeria.

Department of Internal Medicine, Enugu State University of Science and Technology, Enugu, Nigeria.

AA Onwuegbuna, Department of Ophthalmology, Nnamdi Azikiwe University, Awka, Nigeria.

Department of Ophthalmology, Nnamdi Azikiwe University, Awka, Nigeria.

UC Okechukwu, Department of Internal Medicine, Enugu State University of Science and Technology, Enugu, Nigeria.

Department of Internal Medicine, Enugu State University of Science and Technology, Enugu, Nigeria.

AC Anyanwu, Department of Internal Medicine, Federal University Teaching Hospital, Owerri, Nigeria.

Department of Internal Medicine, Federal University Teaching Hospital, Owerri, Nigeria.

HE Ikeabbah, Department of Surgery, Nnamdi Azikiwe University, Awka, Nigeria.

Department of Surgery, Nnamdi Azikiwe University, Awka, Nigeria.

AM Ezeude, Department of Nursing Sciences, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.

Department of Nursing Sciences, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.

References

Gregg EW, Cheng YJ, Srinivasan M, Lin J, Geiss LS, Albright AL et al. trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet. 2018. 16 ; 391(10138):2430 - 2440. https://doi.org/10.1016/S0140-6736(18)30314-3 PMid:29784146

Ezeude CM, Ijeoma UN, Oguejiofor OC, Young EE, Nwatu CB, Onyenekwe BM et al. Asymptomatic Cardiovascular Disorders in a Cohort of Clinically Stable Type 2 Diabetes Mellitus Patients in South Eastern Nigeria: A Cross Sectional Study. JAMMR. 2020; 32(14):58 - 66. https://doi.org/10.9734/jammr/2020/v32i1430590

Nazimek-Siewniak B, Moczulski D, Grzeszczak W. Risk of macrovascularand microvascular complications in type 2 diabetes: Results of longitudinal study design. J Diabetes Complications. 2002; 16 (4):271-276. https://doi.org/10.1016/S1056-8727(01)00184-2 PMid:12126785

Kuzu F. The effect of type 2 diabetes on electrocardiographic markers of significant cardiac event. Pak J Med Sci. 2018; 34(3)626-632. https://doi.org/10.12669/pjms.343.14562 PMid:30034428 PMCid:PMC6041533

Dweck M, Campbell IW, Miller D, Francis CM. Clinical aspect of Silent myocardial ischaemia with particular reference to diabetes mellitus. Br J Diabetes Vasc Dis. 2018; 9:110-116. https://doi.org/10.1177/1474651409105249

Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Boston, Mass: Wright-PSG; 1982.

Bacci S, Villella M, Villella A, Langialonga T, Grilli M, Rauseo A et al. Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk and accuracy of the exercise stress test. Eur J Endocrinol. 2002; 147: 649 - 654. https://doi.org/10.1530/eje.0.1470649 PMid:12444897

Harms PP, van der Heijden AA, Rutters F, Tan HL, Beulens JWJ, Nijpel G et al. Prevalence of ECG abnormalities in people with type 2 diabetes: The Hoorn Diabetes Care System Cohort. J Diabetes Complications. 2021; 25 (2): 107810. https://doi.org/10.1016/j.jdiacomp.2020.107810 PMid:33280986

Stern S, Sclarowsky S, The ECG in Diabetes Mellitus. Circulation. 2009; 120: 1633 - 1636. https://doi.org/10.1161/CIRCULATIONAHA.109.897496 PMid:19841309

International Diabetes Federation Guideline Development Group. Global guideline for type 2 diabetes. Diabetes Res Chin Pract. 2014; 104 (1): 1 - 52. https://doi.org/10.1016/j.diabres.2012.10.001 Mid:24508150

Simova I, Christov I, Bortolan G. A review on electrocardiographic changes in diabetic patients. Curr Diabetes Rev. 2015; 11(2): 103 - 6. https://doi.org/10.2174/1573399811666150113161417 PMid:25584936

Lee MK, Hank, Kim MK, Koh ES, Kim ES, Noam GE et al. Changes in Metabolic Syndrome and its components and the risk of type 2 diabetes: a nationwide cohort study. Sci Rep 2020; 10: 2 - 13. https://doi.org/10.1038/s41598-020-59203-z PMid:32047219 PMCid:PMC7012827

Fluckiger R, Woodtli T, Berger W. Quantitation of glycosylated haemoglobin by boronate affinity chromatography. Diabetes. 1984; 33: 73-76. https://doi.org/10.2337/diabetes.33.1.73 PMid:6690345

Mark V. An improved glucose oxidase method for determining blood, csf, urine glucose levels. Clin Chim Acta. 1996; 251: 19 - 24. https://doi.org/10.1016/0009-8981(96)83704-1 PMid:8814347

Hirano T, Nohtomi K, Koba S, Muroi A, Ito Y. A simple and precise method for measuring HDL-cholesterol subfractions by a single precipitation followed by homogenous HDL-cholesterol assay. J lipid Res. 2008; 49: 1130 - 1136. https://doi.org/10.1194/jlr.D700027-JLR200 PMid:18223297

Allain CC, Poon LS, Chan CSG, Richmond W, Fu C. Enzymatic determination of total serum cholesterol. Clin Chem. 1974; 20: 470 - 475. https://doi.org/10.1093/clinchem/20.4.470 PMid:4818200

Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973; 19: 476 - 482. https://doi.org/10.1093/clinchem/19.5.476 PMid:4703655

Assmann G, Jabs HU, Kohnert U, Nolte W, Schriewer H. LDL-cholesterol determination in blood serum following precipitation of LDL with polyvinylsulphate. Clin Chim Acta. 1984; 140: 77 - 83. https://doi.org/10.1016/0009-8981(84)90153-0 PMid:6744629

Toora BD, Rajagopal G. measurement of creatinine by Jaffe's reaction determination of concentration of sodium hydroxide required for maxmum color development in standard urine and protein free filtrate of serum. Indian J Exp Biol. 2002; 40 (3): 352 - 355. PMD12635710

Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D et al. Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular prediction equation. Ann Intern Med. 1999; 130: 461 - 70. https://doi.org/10.7326/0003-4819-130-6-199903160-00002 PMid:10075613

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42: 1206 - 1252. https://doi.org/10.1161/01.HYP.0000107251.49515.c2 PMid:14656957

World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. WHO/NCD/NCS 99. Geneva ; WHO, 1999; pp 1 - 58.

National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP 111 Final Report). Circulation. 2022; 106: 3141 - 3421.

U.S. Census Bureau, 2012 Population Estimates and 2012 National Projections. https://www.Census.gov

Khanal MK, Bhandari P, Dhungana RR, Gurung Y, Rawal LB, Pandey G, Bhandari M, Bhuiyan R, Devkota S, de Courten M, de Courten B. Electrocardiogram abnormalities and renal impairment in patients with type 2 diabetes mellitus: A healthcare facilities-based cross-sectional study in Dang district of Nepal. J Diabetes Investig. 2023 Apr;14(4):602-613. https://doi.org/10.1111/jdi.13985 PMid:36747483 PMCid:PMC10034961

Sinamaw, D., Getnet, M., Abdulkadir, M. et al. Patterns and associated factors of electrocardiographic abnormality among type 2 diabetic patients in Amhara National Regional State Referral Hospitals, Ethiopia: a multicenter institution-based cross-sectional study. BMC Cardiovasc Disord 22, 230 (2022). https://doi.org/10.1186/s12872-022-02661-2 PMid:35590246 PMCid:PMC9118567

Bedane, D.A., Tadesse, S., Bariso, M. et al. Assessment of electrocardiogram abnormality and associated factors among apparently healthy adult type 2 diabetic patients on follow-up at Jimma Medical Center, Southwest Ethiopia: Cross-sectional study. BMC Cardiovasc Disord 21, 312 (2021). https://doi.org/10.1186/s12872-021-02110-6 PMid:34167465 PMCid:PMC8223340

Sellers MB, Divers J, Lu L, Xu J, Smith SC, Bowden DW et al. Prevalence and determinants of electrocardiographic abnormalities in African Americans with type diabetes. J Epidemol Glob Health. 2014; 4 (4): 289 - 296. https://doi.org/10.1016/j.jegh.2014.04.003 PMid:25455646 PMCid:PMC4254487

Gupta S, Gupta RK, Kulshrestha M, Chaudhary RR. Evaluation of ECG abnormalities in patients with asymptomatic Type 2 Diabetes Mellitus. J Clin Diagn Res. 2017; 11(4): 39-41. https://doi.org/10.7860/JCDR/2017/24882.9740 PMid:28571189 PMCid:PMC5449835

Mantovani A, Rigolon R, Turino T, Pichiri I, Falceri A, Rossi A, Temporelli PL, Bonapace S, Lippi G, Zoppini G, Bonora E, Byrne CD, Targher G. Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes. Diabetes Metab. 2018 Dec;44(6):473-481. https://doi.org/10.1016/j.diabet.2018.08.007 PMid:30195089

Chang YK, Fan HC, Hsu CC, Lim PS. The association between EKG abnormalities and the development of microalbuminuria in type 2 diabetes. Medicine (Baltimore). 2021 Dec 23;100(51):e28018. https://doi.org/10.1097/MD.0000000000028018 PMid:34941042 PMCid:PMC8702232

Published

15-11-2023
Statistics
Abstract Display: 216
PDF Downloads: 161
PDF Downloads: 16

How to Cite

1.
Ezeude C, Nkpozi M, Abonyi M, Onwuegbuna A, Okechukwu U, Anyanwu A, et al. Associations of Electrocardiographic Abnormalities in Stable Type 2 Diabetes Subjects: Experience from a Tertiary Health Facility in South Eastern Nigeria. J. Drug Delivery Ther. [Internet]. 2023 Nov. 15 [cited 2025 Feb. 13];13(11):62-7. Available from: https://jddtonline.info/index.php/jddt/article/view/6006

How to Cite

1.
Ezeude C, Nkpozi M, Abonyi M, Onwuegbuna A, Okechukwu U, Anyanwu A, et al. Associations of Electrocardiographic Abnormalities in Stable Type 2 Diabetes Subjects: Experience from a Tertiary Health Facility in South Eastern Nigeria. J. Drug Delivery Ther. [Internet]. 2023 Nov. 15 [cited 2025 Feb. 13];13(11):62-7. Available from: https://jddtonline.info/index.php/jddt/article/view/6006